Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.

Buskin SE, Barash EA, Scott JD, Aboulafia DM, Wood RW.

World J Gastroenterol. 2011 Apr 14;17(14):1807-16. doi: 10.3748/wjg.v17.i14.1807.

2.

Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.

Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE.

J Infect Public Health. 2013 Jun;6(3):186-95. doi: 10.1016/j.jiph.2012.12.003.

3.

Genetic diversity of hepatitis B virus and hepatitis C virus in human immunodeficiency virus type 1-co-infected patients from Venezuela.

Jaspe RC, Sulbarán YF, Loureiro CL, Martínez N, Devesa M, Rodríguez Y, Torres JR, Rangel HR, Pujol FH.

J Med Microbiol. 2014 Aug;63(Pt 8):1099-104. doi: 10.1099/jmm.0.067496-0.

PMID:
24895404
4.

Testing for hepatitis B virus and HIV in patients with chronic hepatitis C: screening performance and outcome.

Bolther M, Dalgaard LS, Kristensen LH, Tarp BD, Jensen-Fangel S.

Scand J Infect Dis. 2014 Oct;46(10):686-92. doi: 10.3109/00365548.2014.929734.

PMID:
25134654
5.

Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.

Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.

Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0.

PMID:
25616842
6.

Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.

Chandra N, Joshi N, Raju YS, Kumar A, Teja VD.

Indian J Med Res. 2013 Dec;138(6):950-4.

7.

High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.

Rusine J, Ondoa P, Asiimwe-Kateera B, Boer KR, Uwimana JM, Mukabayire O, Zaaijer H, Mugabekazi J, Reiss P, van de Wijgert JH.

PLoS One. 2013 May 22;8(5):e63303. doi: 10.1371/journal.pone.0063303.

8.

Co-infection with hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India.

Kosaraju K, Padukone S, Bairy I.

Trop Doct. 2011 Jul;41(3):170-1. doi: 10.1258/td.2011.110054.

PMID:
21676983
9.

Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.

Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA.

BMC Res Notes. 2013 Sep 9;6:363. doi: 10.1186/1756-0500-6-363.

10.

HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.

Prussing C, Chan C, Pinchoff J, Kersanske L, Bornschlegel K, Balter S, Drobnik A, Fuld J.

Epidemiol Infect. 2015 May;143(7):1408-16. doi: 10.1017/S0950268814002209.

PMID:
25170631
11.

Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.

Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S.

J Infect Dev Ctries. 2013 Jun 15;7(6):453-67. doi: 10.3855/jidc.2965.

12.

Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania.

Franzeck FC, Ngwale R, Msongole B, Hamisi M, Abdul O, Henning L, Letang E, Mwaigomole G, Battegay M, Hatz C, Tanner M.

PLoS One. 2013;8(3):e58468. doi: 10.1371/journal.pone.0058468.

13.

HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India.

Hussain T, Kulshreshtha KK, Sinha S, Yadav VS, Katoch VM.

Int J Infect Dis. 2006 Sep;10(5):358-63.

14.

Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus.

Pontali E, Ferrari F.

Int J Prison Health. 2008;4(2):77-82. doi: 10.1080/17449200802038207.

PMID:
18464061
15.

Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.

Guimarães Nebenzahl H, Lopes A, Castro R, Pereira F.

S Afr Med J. 2013 Jan 24;103(3):186-8. doi: 10.7196/samj.6097.

PMID:
23472697
16.

Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.

Phuangchoei P, Chotiyaputta W, Chayakulkeeree M.

J Med Assoc Thai. 2015 Mar;98(3):226-31.

PMID:
25920291
17.

Spatial epidemiology of HIV-hepatitis co-infection in the State of Michigan: a cohort study.

Butt Z, Grady S, Wilkins M, Hamilton E, Todem D, Gardiner J, Saeed M.

Infect Dis (Lond). 2015;47(12):852-61. doi: 10.3109/23744235.2015.1066931.

PMID:
26179757
18.

Interference of replication between hepatitis B and C viruses in patients infected with HIV.

Yang RR, Gui X, Chen XY, Zhu Y.

J Med Virol. 2011 Jul;83(7):1159-64. doi: 10.1002/jmv.22102.

PMID:
21567419
19.

[Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].

Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.

Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):189-91. Chinese.

PMID:
23967739
20.

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.

Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group..

J Hepatol. 2005 Jun;42(6):799-805.

PMID:
15973779
Items per page

Supplemental Content

Support Center